Special Investigation Of Long Term Use Of Sertraline.
Information source: Pfizer
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Depression; Panic Disorder
Intervention: Sertraline hydrochloride (Drug)
Phase: N/A
Status: Completed
Sponsored by: Pfizer Official(s) and/or principal investigator(s): Pfizer CT.gov Call Center, Study Director, Affiliation: Pfizer
Summary
Special investigation of long term use of sertraline, 52 Week Observation, Long-Term Safety.
The objective of this "Special investigation" is to collect information about 1) adverse
drug reactions not expected from the LPD (unknown adverse drug reactions), 2) the incidence
of adverse drug reactions in this surveillance, and 3) factors considered to affect the
safety and/or efficacy of this drug regarding long time use.
Clinical Details
Official title: Special Investigation Of Long Term Use Of J ZOLOFT.
Study design: Observational Model: Case-Only, Time Perspective: Prospective
Primary outcome: Number of Treatment Related Adverse Events (TRAEs) Not Expected From Japanese Package InsertNumber of Participants of Treatment Related Adverse Events (TRAEs)
Secondary outcome: Risk Factors for Incidence Rate of Treatment Related Adverse Events (TRAEs) of Sertraline: Renal DysfunctionRisk Factors for Incidence Rate of Treatment Related Adverse Events (TRAEs) of Sertraline: Past Medical History of Other Illness Factors Considered to Affect the Efficacy of Sertraline: Non-Pharmaceutical Therapies Factors Considered to Affect the Efficacy of Sertraline: Present or Past History of Intentional Suicidal Ideation (Including Suicide Attempt)
Detailed description:
All the patients for whom an investigator prescribes the first sertraline hydrochloride
should be registered consecutively until the number of subjects reaches target number in
order to extract patients enrolled into the investigation at random.
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
The patients who take sertraline hydrochloride for longer than the duration of 16 weeks
among the patients enrolled in A0501090 (Drug Use Investigation of J Zoloft).
Exclusion Criteria:
Patients not taking sertraline hydrochloride.
Locations and Contacts
Additional Information
To obtain contact information for a study center near you, click here.
Starting date: September 2007
Last updated: August 9, 2012
|